VCM
ARQT icon

Versant Capital Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Versant Capital Management’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1K Hold
80
– – ﹤0.01% 2556
2026
Q1 		$1.89K Hold
80
– – ﹤0.01% 2578
2025
Q4 		$2.32K Sell
80
-135
-63% -$3.46K ﹤0.01% 2427
2025
Q3 		$4.05K Hold
215
– – ﹤0.01% 2289
2025
Q2 		$3.01K Hold
215
– – ﹤0.01% 2300
2025
Q1 		$3.36K Hold
215
– – ﹤0.01% 2173
2024
Q4 		$3K Hold
215
– – ﹤0.01% 1957
2024
Q3 		$2K Buy
+215
New +$2.12K ﹤0.01% 1564

Other funds holding ARQT

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return